Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Mukka Proteins Ltd

MUKKA
NSE
24.03
0.50%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Mukka Proteins Ltd

MUKKA
NSE
24.03
0.50%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
721Cr
Close
Close Price
24.03
Industry
Industry
FMCG Processing - Other
PE
Price To Earnings
16.13
PS
Price To Sales
0.50
Revenue
Revenue
1,450Cr
Rev Gr TTM
Revenue Growth TTM
64.53%
PAT Gr TTM
PAT Growth TTM
-20.68%
Peer Comparison
How does MUKKA stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
MUKKA
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
421274332517257173149303382171245654
Growth YoY
Revenue Growth YoY%
30.2-39.0-37.1-55.0-41.448.6-1.063.9115.6
Expenses
ExpensesCr
376258294498225158140262352156224608
Operating Profit
Operating ProfitCr
451638193214104129152145
OPM
OPM%
10.66.011.43.612.58.26.413.67.68.58.57.0
Other Income
Other IncomeCr
-216853464268
Interest Expense
Interest ExpenseCr
76667891110111315
Depreciation
DepreciationCr
333333443344
PBT
PBTCr
3383517276133202935
Tax
TaxCr
11465-20066127
PAT
PATCr
2242912295127142727
Growth YoY
PAT Growth YoY%
-55.833.019.3-94.9122.0-52.0-69.8368.01.7
NPM
NPM%
5.21.68.62.311.43.01.08.83.70.92.84.2
EPS
EPS
1.00.21.30.51.20.10.10.90.50.10.20.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
4095496047711,1771,3801,0061,450
Growth
Revenue Growth%
34.49.927.652.817.2-27.144.1
Expenses
ExpensesCr
3855255827241,0911,2749121,341
Operating Profit
Operating ProfitCr
232422478610595110
OPM
OPM%
5.74.33.66.17.37.69.47.6
Other Income
Other IncomeCr
281078191619
Interest Expense
Interest ExpenseCr
4781016253749
Depreciation
DepreciationCr
258912121414
PBT
PBTCr
1920153666876066
Tax
TaxCr
5641018131217
PAT
PATCr
1414112648744850
Growth
PAT Growth%
-0.8-18.9134.584.156.4-35.33.4
NPM
NPM%
3.42.51.83.44.05.44.83.4
EPS
EPS
259.8239.60.51.12.03.11.61.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
6662222303030
Reserves
ReservesCr
38516176126366411414
Current Liabilities
Current LiabilitiesCr
137217272274403521610757
Non Current Liabilities
Non Current LiabilitiesCr
201813151712920
Total Liabilities
Total LiabilitiesCr
2012933553925759411,0761,239
Current Assets
Current AssetsCr
1422062572864648179261,049
Non Current Assets
Non Current AssetsCr
598797106111124151191
Total Assets
Total AssetsCr
2012933553925759411,0761,239

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-20-2525-56-150-112
Investing Cash Flow
Investing Cash FlowCr
-23-28-14-11-3-48-35
Financing Cash Flow
Financing Cash FlowCr
345413157526656
Net Cash Flow
Net Cash FlowCr
-91281568-91
Free Cash Flow
Free Cash FlowCr
-39-61-8-1-64-165-130
CFO To PAT
CFO To PAT%
-148.2-184.716.318.9-118.5-202.4-232.7
CFO To EBITDA
CFO To EBITDA%
-86.8-105.48.210.4-65.4-142.6-118.0

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
000001,094981
Price To Earnings
Price To Earnings
0.00.00.00.00.015.621.1
Price To Sales
Price To Sales
0.00.00.00.00.00.81.0
Price To Book
Price To Book
0.00.00.00.00.02.82.2
EV To EBITDA
EV To EBITDA
3.55.97.13.52.712.614.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.313.914.917.620.017.723.0
OPM
OPM%
5.74.33.66.17.37.69.4
NPM
NPM%
3.42.51.83.44.05.44.8
ROCE
ROCE%
18.213.610.416.720.114.810.9
ROE
ROE%
31.124.016.626.332.118.810.9
ROA
ROA%
6.84.63.16.68.37.94.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Mukka Proteins Limited (**MPL**) is India’s dominant force in the marine protein industry, commanding a **25-30%** market share in the domestic fishmeal and fish oil sector. The company operates an integrated "waste-to-value" ecosystem, converting marine discards and organic waste into high-value nutritional ingredients for global aquaculture, livestock, and industrial markets. Following its **March 2024 IPO**, MPL has pivoted toward a "multi-engine growth" model, diversifying into insect-based biotechnology and large-scale environmental services. --- ### **The "Waste-to-Value" Ecosystem: Core Business Verticals** MPL’s operations are built on a circular manufacturing model designed to achieve **zero-waste** and **zero-landfill** objectives by monetizing every output of the production process. #### **1. Marine Protein & Lipids (Core)** The company processes sustainably sourced pelagic fish (sardines and mackerels) into essential feed ingredients: * **Fishmeal:** High-protein (**60-65%**, up to **80%**) supplement for aquaculture, poultry, and pet food. * **Fish Oil:** Rich in **Omega-3 (EPA & DHA)**; used in aquafeed, pharmaceuticals, and veterinary products. * **Fish Soluble Paste:** A nutrient-dense liquid additive that enhances feed palatability, particularly in shrimp farming. * **Frozen & Value-Added:** Forward integration into **Surimi** (capacity: **~5,000 MT p.a.**) and **IQF Frozen Seafood** (shrimp, squid, mackerel) with a freezing capacity of **50 MT per day**. #### **2. Insect Biotech Platform (Alternative Protein)** Through its subsidiary **Ento Proteins**, MPL is a pioneer in commercializing **Black Soldier Fly (BSF)** technology. This vertical upcycles municipal wet waste into sustainable protein: * **Insect Meal & Oil:** Highly digestible, antimicrobial fishmeal substitutes for animal nutrition. * **Organic Inputs:** Production of **Insect Compost**, **Humic Acid**, and **Bio-stimulants** for the horticulture and organic farming sectors. * **Briquettes:** Sustainable fuel generated from BSF waste residues. #### **3. Environmental Services & Carbon Credits** MPL has leveraged its organic processing expertise to enter the high-margin environmental sector: * **Leachate Treatment:** Secured a landmark **₹474.89 crore** order from **Bengaluru Solid Waste Management Limited** for the scientific treatment of legacy leachate over **4 years** (JV stake: **76%**). * **Carbon Credits:** Formally listed **300 TPD** wet waste operations on the **Verra Registry** (Project ID 5893), with approvals to expand to **1,000 TPD** for **Verified Carbon Unit (VCU)** generation. --- ### **Manufacturing Footprint & Global Supply Chain** MPL maintains a geographically diversified production footprint to ensure proximity to raw material hubs and international ports. | Facility Type | Count / Capacity | Strategic Advantage | | :--- | :--- | :--- | | **Total Installed Capacity** | **2,64,390 MT** per year | Largest in India for Fishmeal/Oil | | **Owned Production Units** | **16** | Located in India and **Oman** | | **Total Manufacturing Units** | **24** | Includes owned, 3rd party, and job work | | **Blending & Storage** | **4 / 14** | Strategic West Coast India presence | | **Export Reach** | **25+ Countries** | **75.7%** of revenue from exports (**9MFY26**) | **Key Certifications:** MPL is one of the few Indian companies licensed by **AQSIQ** (China) and holds **MarinTrust**, **GMP+**, **ISO 22000**, and **HACCP** certifications. --- ### **Strategic Growth & Inorganic Expansion** Since its listing, MPL has pursued aggressive consolidation to achieve **100% ownership** of key subsidiaries and expand its international manufacturing base. * **Consolidation:** Increased stakes in **Ento Proteins** (to **100%**), **Haris Marine Products** (to **100%**), and **Ocean Proteins** (to **51%**). * **Capacity Expansion:** Acquired **51%** in **GSM Marine Export** (**₹14 crore**) and **FABBCO** (**₹5.95 crore**) to scale fishmeal and BSF projects. * **International Expansion:** Operates **Ocean Aquatic Proteins LLC** in **Oman** (63% subsidiary) and is finalizing a **70%** stake in **Mukka Proteins Vietnam Co., Ltd** (target: **June 2026**). * **Capital Structure:** Increased authorized share capital to **₹40 crore** and executed a preferential issue at **₹50/share** in **February 2025** to fund expansion. --- ### **Financial Performance & Credit Profile** While MPL has shown strong historical growth, recent years have been marked by volatility and working capital stress. | Metric (₹ Crore) | FY25 (Actual) | FY24 (Actual) | FY23 (Actual) | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | **1,006.41** | **1,379.83** | **1,177.12** | | **Profit After Tax (PAT)** | **48.09** | **74.30** | **47.53** | | **PBILDT Margin** | **10.15%** | **8.25%** | - | | **Net Debt to Equity** | **92.96%** | **55.95%** | **172.34%** | | **Inventory Days** | **210** | **97** | - | **Credit Outlook:** In early **2026**, **CARE Ratings** downgraded the company to **CARE BBB; Negative**. This reflects a **27.06%** revenue contraction in **FY25** and an elongated operating cycle of **226 days**. However, **H1 FY26** showed a recovery with **28% YoY** revenue growth (**₹415 crore**) as global fishmeal prices trended upward. --- ### **Risk Matrix & Mitigation** #### **Operational & Market Risks** * **Seasonality:** Business is highly dependent on fishing bans and climatic changes. Raw material costs exceed **80%** of sales. * **Working Capital:** Operations are capital-intensive; net cash flow from operations was **negative ₹107 crore** in **FY25**. * **Concentration:** The **top 2 customers** account for **40.97%** of revenue. * **Regulatory Barriers:** **MPEDA** has a moratorium on new export registrations for fishmeal, creating high entry barriers but also limiting MPL's own expansion flexibility. #### **Legal & Contingent Liabilities** MPL is currently contesting several tax and regulatory demands: * **Customs:** **₹7.67 crore** regarding Export Obligation Discharge Certificates. * **GST/CGST:** **₹4.37 crore** (IPO expense ITC) and **₹9.82 crore** (Fish Soluble Paste classification). * **Income Tax:** Demands totaling **~₹17 crore** across multiple assessment years following search and seizure actions. #### **Financial Risks** * **Interest Rate Volatility:** Variable rate borrowings increased to **₹355.87 crore** in **2024**. * **Forex:** The company hedges **~50%** of its foreign exchange exposure via forward contracts.